Companies / Kayothera
Kayothera
Seattle, United States
Kayothera develops small molecule inhibitors of the retinoid nuclear receptor pathway for unmet medical needs
Kayothera, based in Seattle, United States, has 2 investors on file, among them 7G BioVentures and Foundation Venture Capital Group. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from 7G BioVentures
11 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
More from Foundation Venture Capital Group
6 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Foundation Venture Capital Group's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Kayothera and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when 7G BioVentures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/kayothera.com/investors
# also
GET /v1/companies/kayothera.com
GET /v1/companies/kayothera.com/news